DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

01177 SINO BIOPHARM

Closed Add to Porfolio
Index Constituent : Hang Seng Index, HS Composite Index, HS Comp.LargeCap Ind, HS Comp. L & M Index, HS China (HK) 100, Stock Connect HK Ind
Major Shareholders Tse, Eric S Y (21.61%)
Cheng Cheung Ling (15.82%)
Tse Ping (8.84%)
Sector Health Care & Biotechnology
Web Site http://www.sinobiopharm.com Tel (852) 2802-9886
Email info@sino-biopharm.com Fax N/A
Related Equities N/A
Principal Activities Principally engaged in the research and development, production and sale of a series of modernised Chinese medicines and chemical medicines.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
鄭翔玲 2,832,056,500(L)  22.41(L)  07/12/2018
謝炳 1,833,790,083(L)  14.51(L)  19/06/2018
謝其潤 1,519,503,174(L)  12.02(L)  19/06/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
謝其潤 1,519,503,174(L)  12.02(L)  19/06/2018
謝炘 98,598,000(L)  0.78(L)  19/06/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top